Treat cancers by targeting survivin: Just a dream or future reality?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Treat cancers by targeting survivin: Just a dream or future reality?

Published:2013-11 Issue:7 Volume:39 Page:802-811
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

Coumar Mohane Selvaraj,Tsai Fang-Ying,Kanwar Jagat Rakesh,Sarvagalla Sailu,Cheung Chun Hei Antonio

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Reference113 articles.

1. Survivin expression in breast cancer predicts clinical outcome and is associated with HER2, VEGF, urokinase plasminogen activator and PAI-1;Ryan;Ann Oncol,2006

2. Survivin in esophageal cancer: an accurate prognostic marker for squamous cell carcinoma but not adenocarcinoma;Rosato;Int J Cancer,2006

3. Survivin, survivin-2B, and survivin-deItaEx3 expression in medulloblastoma: biologic markers of tumour morphology and clinical outcome;Fangusaro;Br J Cancer,2005

4. Expression of survivin is correlated with cancer cell apoptosis and is involved in the development of human pancreatic duct cell tumors;Satoh;Cancer,2001

5. Expression of survivin correlates with apoptosis, proliferation, and angiogenesis during human colorectal tumorigenesis;Kawasaki;Cancer,2001

Cited by 129 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. First-in-human clinical trial results with ABBV-184, a first-in-class T-cell receptor/anti-CD3 bispecific protein, in adults with previously treated AML or NSCLC;Expert Review of Anticancer Therapy;2024-07-10

2. Oxidative tryptamine dimers from Corynebacterium durum directly target survivin to induce AIF-mediated apoptosis in cancer cells;Biomedicine & Pharmacotherapy;2024-04

3. Overview of role of survivin in cancer: expression, regulation, functions, and its potential as a therapeutic target;Journal of Drug Targeting;2024-02

4. Unraveling the Impact of Aberrant Splicing Machinery on Drug Resistance in Breast Cancer: Identifying Targets for Innovative Counteractive Strategies;Overcoming Breast Cancer Therapy Resistance;2024

5. Targeting survivin for cancer therapy: Strategies, small molecule inhibitors and vaccine based therapeutics in development;Life Sciences;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3